Monthly Archives: junio 2026

Perfusfind S.L.

Abstract Objectives Diabetes and peri-operative hyperglycaemia are associated with increased morbidity and mortality following cardiac surgery. Despite this, specific guidance on peri-operative glycaemic management during cardiac surgery is lacking in United..

Perfusfind S.L.

Abstract Oxidative stress injury is a critical complication during long-term extracorporeal membrane oxygenation (ECMO) support and is further aggravated in critically ill patients with diabetic metabolic comorbidities. Nevertheless, conventional ECMO..

Perfusfind S.L.

What the review examined The investigators searched PubMed, the Cochrane Library, Web of Science, Embase, and ClinicalTrials.gov, with a final search on February 9, 2026. The review followed JBI and..

Perfusfind S.L.

Abstract Objectives To investigate whether cardiopulmonary bypass (CPB)-induced platelet dysfunction is associated with dysregulated autophagic flux in patients undergoing cardiac surgery. Design Prospective, single-center observational study. Setting A tertiary university..

Perfusfind S.L.

Abstract Background Autotransfusion devices concentrate white blood cells (WBCs) within the washed product that may lead to undesirable clinical effects when reinfused to the patient. This quality improvement project evaluated..

Perfusfind S.L.

Abstract Background The effects of hollow fiber membrane (HFM) configuration on hemodynamic characteristics, oxygen transfer performance, and thrombosis risk in oxygenators are not clear, and the present study was accomplished..

Perfusfind S.L.

Abstract Background This review aims to provide a concise summary of hemodynamic considerations and the pharmacology and current evidence of vasoactive support, including inotropes and vasopressors, during extracorporeal membrane oxygenation..

Perfusfind S.L.

Abstract Background: Del Nido cardioplegia (DNC) has extensively been used for pediatric population undergoing cardiac surgery. However, its use in adult cardiac surgeries have been limited thus, its benefits are..

Perfusfind S.L.

International Society for Organ Preservation and Perfusion Therapy (ISOPPT) 1st isoppt congress Date: February 19th-20th, 2027 Venue: Turin, Italy CONGRESS PRESIDENT: Renato Romagnoli

Perfusfind S.L.

Abstract Background Acute type A aortic dissection (ATAAD) is a surgical emergency associated with high mortality. While patient-related risk factors are well-established, beliefs persist regarding the influence of lunar phases,..

Perfusfind S.L.

27th October 2026, 16:00-17:30 CET Reducing Anticoagulation in ECMO Moderators: Mark Davidson, Nina Buchtele Speakers and Schedule: 16:00 | Introduction            Mark Davidson (United Kingdom), Nina..

Perfusfind S.L.

Dear colleagues, members and friends, The EuroELSO Team and faculty are delighted to invite you to the EuroELSO Congress in Vienna, taking place from April 28th to May 1st, 2027,..

Perfusfind S.L.

Abstract Over half a century ago, modelling and simulation of human cardiopulmonary physiology emerged as a research methodology, comparable to laboratory experiments and clinical studies. However, teaching fundamental physiological modelling..

Perfusfind S.L.

Abstract Background: Pediatric cardiac surgery requiring cardiopulmonary bypass (CPB) is associated with high transfusion rates. While transfusions increase risks of adverse events, existing evidence cannot differentiate whether risks arise from..

Perfusfind S.L.

Abstract Background Neurological complications are among the most serious adverse events in patients receiving extracorporeal membrane oxygenation (ECMO). Brain injury during ECMO is associated with increased mortality, long-term neurological deficits..

Perfusfind S.L.

Abstract Objectives To evaluate whether an activated clotting time (ACT)-guided, formula-based anticoagulation strategy supported by viscoelastic coagulation monitoring (ROTEM) improves perioperative coagulation management and reduces bleeding compared with standard weight-based..

Perfusfind S.L.

Abstract Objective To describe the application of a cell saver device (CSD) to manage blood loss in dogs and cats. Study design Retrospective study. Animals A total of 102 client-owned..

Perfusfind S.L.

Abstract Background Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) (VV-ECMO) and Veno-Artial Extracorporeal Membrane Oxygenation (VA-ECMO) have become evidence-based therapy options for patients with most severe heart and/or lung failure. Cannulas continue..

Perfusfind S.L.

Abstract Objectives: To describe the rate, characteristics, and outcomes of pediatric extracorporeal cardiopulmonary resuscitation (ECPR) for in-hospital cardiac arrest (IHCA) in Japan and evaluate temporal trends. Design: Retrospective cohort using..

Perfusfind S.L.

Abstract Operating room personnel are exposed to biological hazards such as needlestick injuries and blood and body fluid exposure, which pose risks of bloodborne infections. However, many of these incidents..

Perfusfind S.L.

Take part in an intensive and interactive course designed for a small group of participants. Maximum 40 participants with 10 simulation stations. The course will be the same as used..

Perfusfind S.L.

Join up to 400 healthcare professionals for an international congress featuring an engaging scientific programme, inspiring speakers and opportunities to meet and exchange experiences with colleagues. Lunch on both days..

Perfusfind S.L.

  We are pleased to announce an upcoming academic session on “Gastric Mucormycosis on VV ECMO: A Rare Presentation”, organized by the Institute of Critical Care Medicine & ECMO, in..

Perfusfind S.L.

Abstract Background Postcardiopulmonary bypass (CPB) bleeding is partly driven by impaired thrombin generation. Recent trials suggest differing clinical effects of fresh frozen plasma (FFP) and prothrombin complex concentrate (PCC), but..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is an invaluable tool in cardiac surgery. In pediatric patients, it is almost exclusively deployed by congenital cardiac surgeons who are sufficiently trained. Pediatric ECMO..

Perfusfind S.L.

Abstract Support with veno-venous extracorporeal membrane oxygenation (VV-ECMO) can be considered for patients with severe (combined) hypoxemia and hypercapnia. By adjusting sweep gas flow (SGF), blood oxygenation and correction of..

Perfusfind S.L.

Abstract Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is often combined with other temporary mechanical circulatory support (tMCS) in cardiogenic shock, yet combination-specific outcomes remain poorly defined. We compared temporal trends,..

Perfusfind S.L.

Abstract Donation following the confirmation of death based on circulatory criteria has proven to be a valuable strategy for increasing the availability of organs for transplantation. However, the standard super-rapid..

Perfusfind S.L.

Abstract Background: Myocardial ischemia–reperfusion during cardiac surgery is associated with complex metabolic alterations that reflect both myocardial injury and recovery. This prospective study aimed to characterize intraoperative lactate, pH, and..

Perfusfind S.L.

Abstract Background Veno-venous extracorporeal membrane oxygenation (VV ECMO) candidacy decisions are made under substantial uncertainty and are inconsistent. With a team including economist decision-scientists, we applied Regret Theory to hypothesize..